Dec 14 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BRANDED CARDIOVASCULAR DRUG IN THE U.S.
* MEDICURE INC - LICENSING AGREEMENT IS FOR A TERM OF SEVEN YEARS WITH EXTENSIONS TO TERM AVAILABLE
* MEDICURE - THROUGH ITS SUBSIDIARY CO HAS ACQUIRED LICENSE TO SELL AND MARKET A BRANDED CARDIOVASCULAR DRUG IN UNITED STATES AND ITS TERRITORIES
* MEDICURE - CO INTENDS TO LAUNCH THE PRODUCT WITH A TARGET COMMERCIAL LAUNCH DATE IN H1 OF 2018